Medinotec MDNC
OTC MDNC
$5.00 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Medinotec (MDNC) Current Deferred Revenue (2023)

Updated

Medinotec's Current Deferred Revenue came in at $64,640 for fiscal Q3 2024 (quarter ended Nov 30, 2023), up 26.3% from the prior quarter.

Analysis

Medinotec (MDNC) Current Deferred Revenue (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Medinotec 58.78 Mn 50.33 Mn 1.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2023 64,640.00
Aug 31, 2023 51,170.00
API Access

Medinotec Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MDNC&period=max&api_key=YOUR_API_KEY